XML 77 R70.htm IDEA: XBRL DOCUMENT v3.25.2
Stock Options and Restricted Stock - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 15, 2018
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Feb. 29, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Stock option outstanding   838,813 [1] 889,928 [1]   838,813 [1]   913,909 959,522  
Stock option exercisable   838,813 [1]     838,813 [1]   829,286    
Unvested shares of common stock outstanding   0 0   0   84,623 261,875  
Number of shares vested and settled         323,977        
Unrecognized compensation cost related to unvested stock options, restricted stock, restricted stock units, and performance stock units   $ 8.1     $ 8.1        
Unrecognized compensation cost related to unvested stock options and restricted stock, recognition period         11 months        
Total stock based compensation expense   $ 1.7   $ 1.6 $ 3.4 $ 3.1      
Stock based compensation award per diluted common share   $ 0.07   $ 0.07 $ 0.14 $ 0.13      
Intrinsic value of options vested         $ 0.1        
Restricted Stock Units [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares outstanding   410,387     410,387        
Number of shares outstanding, vested restricted stock units   323,977     323,977        
Restricted Stock Units [Member] | Vest on June 12, 2026 [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares, granted   86,410     86,410        
Weighted average grant price, granted   $ 9.49     $ 9.49        
Restricted Stock Units [Member] | Vest on June 11, 2025 [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares, granted             92,350    
Weighted average grant price, granted             $ 8.23    
Restricted Shares [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares outstanding   727,415 [2] 727,891 [2]   727,415 [2]   909,028 995,376  
Number of shares vested and settled   0 484,823 [3]       400,985 [3]    
Weighted average fair value of options granted         $ 0 $ 0      
Number of shares, granted   0 307,059       347,158    
Weighted average grant price, granted   $ 0 $ 8.47       $ 9.17    
PSU [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares outstanding   823,854 823,854   823,854   512,131 296,444  
Number of shares vested and settled   0 0       0    
Number of shares, granted   0 311,723       215,687    
Weighted average grant price, granted   $ 0 $ 8.47       $ 8.97    
Unvested Performance Shares [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares outstanding, performance stock units   823,854     823,854        
Maximum [Member] | PSU [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Award vesting rights, percentage               200.00%  
Minimum [Member] | PSU [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Award vesting rights, percentage               0.00%  
2018 Equity Incentive Plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for grant   7,710,968     7,710,968        
Shares were rolled into the 2018 Plan   2,287,437     2,287,437        
2018 Equity Incentive Plan [Member] | Restricted Stock Units [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares outstanding   86,410     86,410        
2018 Restricted Stock Plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Unvested shares of common stock outstanding   727,415     727,415        
2015 Director Plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for grant 258,334               300,000
2015 Director Plan [Member] | Non Employee Director One [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for grant 12,000                
2015 Director Plan [Member] | Maximum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period 10 years                
Amended Director Plan [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for grant                 200,000
Number of additional shares available for issuance   0     0        
Amended Director Plan [Member] | Director [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Number of shares available for grant   9,000     9,000        
Amended Director Plan [Member] | Maximum [Member]                  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period 10 years                
[1] The aggregate intrinsic value of outstanding options, which represents the difference between the price of the Company’s common stock at June 30, 2025 and the related exercise price of the underlying options, was $2.5 million for outstanding options, all of which had previously vested. The remaining contractual life was 4.7 years for outstanding options at June 30, 2025
[2] The aggregate fair value of the restricted stock was $6.9 million as of June 30, 2025. The remaining vesting period was 2.7 years at June 30, 2025.
[3] The aggregate fair value of the restricted stock vested was $4.2 million for the six months ended June 30, 2025 and $2.7 million for the year ended December 31, 2024